Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Amphastar Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Amphastar Pharmaceuticals, Inc. with status Current. The shortage was first posted on Feb 22, 2012.

Shortage details

Status
Current
Company
Amphastar Pharmaceuticals, Inc.
Package NDC
76329-3390-1
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)
Initial Posting
Feb 22, 2012

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.